ARCN | News

Heart problems in COPD patients increase mortality risk – Important distinctions for targeted treatments

Asthma and COPD – Who benefits from anti-IL-33 therapy?

How the immunoproteasome sustains chronic inflammation in COPD

Predictions based on genetic risk indicate poorer lung function in early childhood